CN109475821A - 用于麻醉回路中的中空纤维膜 - Google Patents
用于麻醉回路中的中空纤维膜 Download PDFInfo
- Publication number
- CN109475821A CN109475821A CN201780024640.8A CN201780024640A CN109475821A CN 109475821 A CN109475821 A CN 109475821A CN 201780024640 A CN201780024640 A CN 201780024640A CN 109475821 A CN109475821 A CN 109475821A
- Authority
- CN
- China
- Prior art keywords
- component
- film
- weight
- temperature
- polymers compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003444 anaesthetic effect Effects 0.000 title claims abstract description 57
- 239000012528 membrane Substances 0.000 title claims abstract description 55
- 239000000835 fiber Substances 0.000 title abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 112
- 229920000642 polymer Polymers 0.000 claims abstract description 89
- 239000002904 solvent Substances 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 239000002826 coolant Substances 0.000 claims abstract description 40
- 235000012489 doughnuts Nutrition 0.000 claims abstract description 32
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000012456 homogeneous solution Substances 0.000 claims abstract description 17
- 238000000926 separation method Methods 0.000 claims abstract description 14
- 229920000306 polymethylpentene Polymers 0.000 claims abstract description 10
- 239000011116 polymethylpentene Substances 0.000 claims abstract description 10
- 230000035699 permeability Effects 0.000 claims description 34
- 238000013517 stratification Methods 0.000 claims description 32
- 238000005259 measurement Methods 0.000 claims description 29
- 238000001816 cooling Methods 0.000 claims description 23
- 238000005191 phase separation Methods 0.000 claims description 14
- 239000007791 liquid phase Substances 0.000 claims description 13
- 239000012071 phase Substances 0.000 claims description 12
- 238000007711 solidification Methods 0.000 claims description 11
- 230000008023 solidification Effects 0.000 claims description 11
- 239000012510 hollow fiber Substances 0.000 claims description 8
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 8
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 5
- 230000007704 transition Effects 0.000 claims description 5
- -1 2- ethoxy Chemical group 0.000 claims description 4
- 230000002776 aggregation Effects 0.000 claims description 4
- 238000004220 aggregation Methods 0.000 claims description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 4
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 claims description 4
- 239000001087 glyceryl triacetate Substances 0.000 claims description 4
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 4
- 230000002209 hydrophobic effect Effects 0.000 claims description 4
- 229960002622 triacetin Drugs 0.000 claims description 4
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 claims description 2
- 150000001412 amines Chemical class 0.000 claims description 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 239000003760 tallow Substances 0.000 claims description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 claims 2
- 150000001336 alkenes Chemical class 0.000 claims 1
- 239000007789 gas Substances 0.000 description 84
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 49
- 229910002092 carbon dioxide Inorganic materials 0.000 description 42
- 239000000243 solution Substances 0.000 description 42
- 239000001569 carbon dioxide Substances 0.000 description 29
- 229960004424 carbon dioxide Drugs 0.000 description 19
- 239000012530 fluid Substances 0.000 description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 16
- 229910052760 oxygen Inorganic materials 0.000 description 16
- 239000001301 oxygen Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 14
- 229960002078 sevoflurane Drugs 0.000 description 13
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical compound FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 description 13
- 238000012546 transfer Methods 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 229960003537 desflurane Drugs 0.000 description 7
- DPYMFVXJLLWWEU-UHFFFAOYSA-N desflurane Chemical compound FC(F)OC(F)C(F)(F)F DPYMFVXJLLWWEU-UHFFFAOYSA-N 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000001764 infiltration Methods 0.000 description 6
- 230000008595 infiltration Effects 0.000 description 6
- 229960002725 isoflurane Drugs 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- 206010002091 Anaesthesia Diseases 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000037005 anaesthesia Effects 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000003994 anesthetic gas Substances 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000012465 retentate Substances 0.000 description 4
- AZUYLZMQTIKGSC-UHFFFAOYSA-N 1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one Chemical compound ClC=1C(=C2C=NNC2=CC=1C)C=1C(=NN(C=1C)C1CC2(CN(C2)C(C=C)=O)C1)C=1C=C2C=NN(C2=CC=1)C AZUYLZMQTIKGSC-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000000280 densification Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229940126062 Compound A Drugs 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- ZPGKBYMJBZKMAM-UHFFFAOYSA-I calcium;potassium;barium(2+);pentahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[K+].[Ca+2].[Ba+2] ZPGKBYMJBZKMAM-UHFFFAOYSA-I 0.000 description 2
- 229960001777 castor oil Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000006213 oxygenation reaction Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000010215 titanium dioxide Nutrition 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 240000000528 Ricinus communis Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229920005523 TPX™ DX845 Polymers 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- GCNLQHANGFOQKY-UHFFFAOYSA-N [C+4].[O-2].[O-2].[Ti+4] Chemical compound [C+4].[O-2].[O-2].[Ti+4] GCNLQHANGFOQKY-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229940026085 carbon dioxide / oxygen Drugs 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229940052308 general anesthetics halogenated hydrocarbons Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- HUAUNKAZQWMVFY-UHFFFAOYSA-M sodium;oxocalcium;hydroxide Chemical compound [OH-].[Na+].[Ca]=O HUAUNKAZQWMVFY-UHFFFAOYSA-M 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/22—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by diffusion
- B01D53/228—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by diffusion characterised by specific membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/22—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by diffusion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/02—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor characterised by their properties
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/08—Hollow fibre membranes
- B01D69/087—Details relating to the spinning process
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/26—Polyalkenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D53/00—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols
- B01D53/22—Separation of gases or vapours; Recovering vapours of volatile solvents from gases; Chemical or biological purification of waste gases, e.g. engine exhaust gases, smoke, fumes, flue gases, aerosols by diffusion
- B01D2053/221—Devices
- B01D2053/223—Devices with hollow tubes
- B01D2053/224—Devices with hollow tubes with hollow fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2256/00—Main component in the product gas stream after treatment
- B01D2256/10—Nitrogen
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2257/00—Components to be removed
- B01D2257/50—Carbon oxides
- B01D2257/504—Carbon dioxide
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2259/00—Type of treatment
- B01D2259/45—Gas separation or purification devices adapted for specific applications
- B01D2259/4533—Gas separation or purification devices adapted for specific applications for medical purposes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/02—Details relating to pores or porosity of the membranes
- B01D2325/022—Asymmetric membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/02—Details relating to pores or porosity of the membranes
- B01D2325/022—Asymmetric membranes
- B01D2325/023—Dense layer within the membrane
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/02—Details relating to pores or porosity of the membranes
- B01D2325/022—Asymmetric membranes
- B01D2325/0231—Dense layers being placed on the outer side of the cross-section
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/04—Characteristic thickness
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/20—Specific permeability or cut-off range
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/38—Hydrophobic membranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02C—CAPTURE, STORAGE, SEQUESTRATION OR DISPOSAL OF GREENHOUSE GASES [GHG]
- Y02C20/00—Capture or disposal of greenhouse gases
- Y02C20/40—Capture or disposal of greenhouse gases of CO2
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Abstract
Description
Claims (15)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16166434.7A EP3235558A1 (en) | 2016-04-21 | 2016-04-21 | Hollow fiber membrane for use in an anesthetic circuit |
EP16166434.7 | 2016-04-21 | ||
PCT/US2017/028525 WO2017184817A1 (en) | 2016-04-21 | 2017-04-20 | Hollow fiber membrane for use in an anesthetic circuit |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109475821A true CN109475821A (zh) | 2019-03-15 |
CN109475821B CN109475821B (zh) | 2021-10-26 |
Family
ID=56072193
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201780024640.8A Active CN109475821B (zh) | 2016-04-21 | 2017-04-20 | 用于麻醉回路中的中空纤维膜 |
Country Status (7)
Country | Link |
---|---|
US (2) | US10926214B2 (zh) |
EP (2) | EP3235558A1 (zh) |
JP (1) | JP7105197B2 (zh) |
CN (1) | CN109475821B (zh) |
BR (1) | BR112018071647A2 (zh) |
RU (1) | RU2705083C1 (zh) |
WO (1) | WO2017184817A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888946A (zh) * | 2020-08-17 | 2020-11-06 | 杭州科百特科技有限公司 | 一种非对称疏水性聚烯烃中空纤维膜及其制备方法与用途 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6464094B2 (ja) * | 2012-12-22 | 2019-02-06 | ディエムエフ・メディカル・インコーポレーテッド | 中空糸膜を有する麻酔回路 |
US20180126329A1 (en) * | 2016-11-04 | 2018-05-10 | Eaton Corporation | Tube sheet design for use in air separation modules |
DE102019203837A1 (de) | 2019-03-20 | 2020-09-24 | Fresenius Medical Care Deutschland Gmbh | Anlage und Verfahren zur Herstellung von Hohlfasermembranen |
CN112403289B (zh) * | 2020-10-21 | 2021-09-07 | 清华大学 | 一种具有梯度孔结构的聚(4-甲基-1-戊烯)中空纤维膜及其制备方法 |
CN114504955B (zh) * | 2022-03-10 | 2023-02-28 | 北京师范大学 | 一种低温热致相分离制备聚合物多孔膜的方法及其产品 |
CN114832649B (zh) * | 2022-04-21 | 2023-06-16 | 天津大学温州安全(应急)研究院 | 基于绿色稀释剂的聚4-甲基-1-戊烯中空纤维膜及其制备方法和应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6497752B1 (en) * | 1999-01-21 | 2002-12-24 | Membrana Gmbh | Integrally asymmetrical polyolefin membrane |
US20050145107A1 (en) * | 2002-01-24 | 2005-07-07 | Erich Kessler | Polyolefin membrane with integrally asymmetrical tructure and process for producing such a membrane |
CN102420114A (zh) * | 2002-06-03 | 2012-04-18 | 3M创新有限公司 | 层压体以及用该层压体制造超薄基片的方法和设备 |
CN102725008A (zh) * | 2009-08-07 | 2012-10-10 | 汉莫堤克股份有限公司 | 用于消除体液中的生物学有害物质的装置和方法 |
WO2014094139A1 (en) * | 2012-12-22 | 2014-06-26 | Dmf Medical Incorporated | An anesthetic circuit having a hollow fiber membrane |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4519909A (en) | 1977-07-11 | 1985-05-28 | Akzona Incorporated | Microporous products |
US4564488A (en) | 1978-07-31 | 1986-01-14 | Akzo Nv | Methods for the preparation of porous fibers and membranes |
EP0133882B1 (de) | 1983-07-30 | 1990-04-04 | Akzo Patente GmbH | Poren aufweisende Formkörper |
EP0299381B2 (en) | 1987-07-11 | 1999-06-30 | Dainippon Ink And Chemicals, Inc. | Membrane-type artificial lung and method of using it |
US5102432A (en) | 1990-12-10 | 1992-04-07 | Union Carbide Industrial Gases Technology Corporation | Three-stage membrane gas separation process and system |
AU737347B2 (en) | 1997-07-23 | 2001-08-16 | 3M Innovative Properties Company | Integrally asymmetrical polyolefin membrane for gas exchange |
US6375876B1 (en) * | 1999-01-22 | 2002-04-23 | Membrana Gmbh | Method for producing an integrally asymmetrical polyolefin membrane |
WO2012174649A1 (en) | 2011-06-20 | 2012-12-27 | Dmf Medical Incorporated | An anesthetic circuit and a method for using the anesthetic circuit |
CN104707490A (zh) * | 2015-02-09 | 2015-06-17 | 杭州费尔过滤技术有限公司 | 一种超细聚烯烃脱气膜的制备方法 |
-
2016
- 2016-04-21 EP EP16166434.7A patent/EP3235558A1/en not_active Ceased
-
2017
- 2017-04-20 RU RU2018136090A patent/RU2705083C1/ru active
- 2017-04-20 WO PCT/US2017/028525 patent/WO2017184817A1/en active Application Filing
- 2017-04-20 US US16/094,833 patent/US10926214B2/en active Active
- 2017-04-20 JP JP2018555653A patent/JP7105197B2/ja active Active
- 2017-04-20 EP EP17720351.0A patent/EP3445478A1/en not_active Withdrawn
- 2017-04-20 BR BR112018071647A patent/BR112018071647A2/pt not_active Application Discontinuation
- 2017-04-20 CN CN201780024640.8A patent/CN109475821B/zh active Active
-
2021
- 2021-01-21 US US17/154,878 patent/US20210170328A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6497752B1 (en) * | 1999-01-21 | 2002-12-24 | Membrana Gmbh | Integrally asymmetrical polyolefin membrane |
US20050145107A1 (en) * | 2002-01-24 | 2005-07-07 | Erich Kessler | Polyolefin membrane with integrally asymmetrical tructure and process for producing such a membrane |
CN102420114A (zh) * | 2002-06-03 | 2012-04-18 | 3M创新有限公司 | 层压体以及用该层压体制造超薄基片的方法和设备 |
CN102725008A (zh) * | 2009-08-07 | 2012-10-10 | 汉莫堤克股份有限公司 | 用于消除体液中的生物学有害物质的装置和方法 |
WO2014094139A1 (en) * | 2012-12-22 | 2014-06-26 | Dmf Medical Incorporated | An anesthetic circuit having a hollow fiber membrane |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111888946A (zh) * | 2020-08-17 | 2020-11-06 | 杭州科百特科技有限公司 | 一种非对称疏水性聚烯烃中空纤维膜及其制备方法与用途 |
Also Published As
Publication number | Publication date |
---|---|
US10926214B2 (en) | 2021-02-23 |
CN109475821B (zh) | 2021-10-26 |
WO2017184817A1 (en) | 2017-10-26 |
EP3445478A1 (en) | 2019-02-27 |
US20190091626A1 (en) | 2019-03-28 |
EP3235558A1 (en) | 2017-10-25 |
US20210170328A1 (en) | 2021-06-10 |
BR112018071647A2 (pt) | 2019-02-19 |
RU2705083C1 (ru) | 2019-11-01 |
JP2019514671A (ja) | 2019-06-06 |
JP7105197B2 (ja) | 2022-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109475821A (zh) | 用于麻醉回路中的中空纤维膜 | |
JP4791632B2 (ja) | ガス交換のための一体型非対称ポリオレフィン膜 | |
JP4996011B2 (ja) | 一体型非対称ポリオレフィン膜 | |
Bakeri et al. | Effect of polymer concentration on the structure and performance of polyetherimide hollow fiber membranes | |
AU2007312413B2 (en) | Hollow fiber membrane and method for manufacturing thereof | |
JP4217627B2 (ja) | インテグラル非対称構造を有するポリオレフィン膜の製造法 | |
JP6438012B2 (ja) | 微多孔質ポリフッ化ビニリデン膜 | |
CN111888946B (zh) | 一种用于血液氧合的非对称疏水性聚烯烃中空纤维膜及其制备方法与用途 | |
KR20010103749A (ko) | 일체화된 비대칭성 폴리올레핀 막의 제조방법 | |
JP2023166376A (ja) | バイオベースのスルホンポリマーから得られる膜の使用を含む精製方法 | |
CN112535956B (zh) | 一种用于氧合膜的超疏水聚烯烃中空纤维膜及其制备方法 | |
TW201302293A (zh) | 血液處理用中空絲膜及中空絲膜型血液處理裝置 | |
CN113398773B (zh) | 聚(4-甲基-1-戊烯)中空纤维合金膜及其制备方法和应用 | |
CA2839670A1 (en) | An anesthetic circuit and a method for using the anesthetic circuit | |
CN106268377A (zh) | 一种聚砜中空纤维血液透析膜及其制备方法 | |
CN114602333B (zh) | 一种聚4-甲基-1-戊烯中空纤维膜的制备方法 | |
JP3051510B2 (ja) | 体外循環回路装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240415 Address after: American Minnesota Patentee after: 3M INNOVATIVE PROPERTIES Co. Country or region after: U.S.A. Address before: American Minnesota Patentee before: 3M INNOVATIVE PROPERTIES Co. Country or region before: U.S.A. Patentee before: DMF MEDICAL Inc. Country or region before: Canada |
|
TR01 | Transfer of patent right |
Effective date of registration: 20240423 Address after: American Minnesota Patentee after: Shuwanuo Intellectual Property Co. Country or region after: U.S.A. Address before: American Minnesota Patentee before: 3M INNOVATIVE PROPERTIES Co. Country or region before: U.S.A. |